LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2019. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,484,000 | -27.2% | 465,247 | -2.6% | 0.01% | 0.0% |
| Q1 2022 | $2,038,000 | +0.7% | 477,688 | +9.7% | 0.01% | 0.0% |
| Q4 2021 | $2,023,000 | +37.9% | 435,387 | +18.3% | 0.01% | +33.3% |
| Q3 2021 | $1,467,000 | +7.0% | 368,168 | +14.9% | 0.01% | +20.0% |
| Q2 2021 | $1,371,000 | +181.5% | 320,392 | +178.7% | 0.01% | +150.0% |
| Q1 2021 | $487,000 | -59.0% | 114,946 | -58.8% | 0.00% | -60.0% |
| Q2 2020 | $1,187,000 | +889.2% | 278,664 | +879.5% | 0.01% | +400.0% |
| Q1 2020 | $120,000 | -26.4% | 28,449 | -31.7% | 0.00% | 0.0% |
| Q4 2019 | $163,000 | +805.6% | 41,626 | +6414.2% | 0.00% | – |
| Q3 2015 | $18,000 | -18.2% | 639 | -27.4% | 0.00% | – |
| Q2 2015 | $22,000 | – | 880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |